Jubilant Pharmova Ltd
NSE:JUBLPHARMA
Jubilant Pharmova Ltd
NSE:JUBLPHARMA
Price:
909.5
INR
0.34%
Market Closed
Market Cap:
144.1B
INR
Balance Sheet
Balance Sheet Decomposition
Jubilant Pharmova Ltd
Jubilant Pharmova Ltd
| Current Assets | 35B |
| Cash & Short-Term Investments | 12.9B |
| Receivables | 8.3B |
| Other Current Assets | 13.8B |
| Non-Current Assets | 84.2B |
| Long-Term Investments | 631m |
| PP&E | 42.7B |
| Intangibles | 35.5B |
| Other Non-Current Assets | 5.4B |
Balance Sheet
Jubilant Pharmova Ltd
Jubilant Pharmova Ltd
Currency: INR
Millions
Annual
| Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
3 825
|
3 304
|
4 473
|
2 392
|
9 999
|
12 254
|
4 979
|
9 803
|
10 108
|
9 539
|
|
| Cash |
0
|
0
|
0
|
2 241
|
7 174
|
8 559
|
4 758
|
9 512
|
9 928
|
9 032
|
|
| Cash Equivalents |
3 825
|
3 304
|
4 473
|
151
|
2 825
|
3 695
|
221
|
291
|
180
|
507
|
|
| Short-Term Investments |
7
|
216
|
0
|
46
|
3 483
|
1 630
|
1 632
|
0
|
0
|
0
|
|
| Total Receivables |
10 364
|
12 435
|
11 904
|
14 265
|
16 563
|
16 479
|
10 313
|
11 469
|
12 125
|
12 709
|
|
| Accounts Receivables |
8 640
|
9 505
|
10 053
|
11 308
|
12 715
|
12 932
|
8 199
|
9 280
|
10 515
|
10 143
|
|
| Other Receivables |
1 724
|
2 930
|
1 851
|
2 957
|
3 848
|
3 547
|
2 114
|
2 189
|
1 610
|
2 566
|
|
| Inventory |
12 419
|
12 197
|
12 435
|
14 246
|
14 492
|
18 792
|
11 429
|
12 861
|
14 215
|
13 038
|
|
| Other Current Assets |
609
|
602
|
669
|
949
|
1 311
|
1 230
|
1 173
|
960
|
1 176
|
3 475
|
|
| Total Current Assets |
27 224
|
28 753
|
29 481
|
31 898
|
45 848
|
50 383
|
29 525
|
35 092
|
37 624
|
38 761
|
|
| PP&E Net |
31 949
|
32 616
|
33 147
|
34 926
|
38 878
|
42 875
|
25 752
|
27 911
|
33 651
|
36 871
|
|
| PP&E Gross |
0
|
32 616
|
33 147
|
34 926
|
38 878
|
42 875
|
25 752
|
27 911
|
33 651
|
36 871
|
|
| Accumulated Depreciation |
0
|
2 162
|
4 304
|
6 690
|
9 440
|
12 246
|
9 928
|
12 401
|
15 176
|
19 972
|
|
| Intangible Assets |
5 898
|
6 230
|
7 136
|
6 912
|
7 031
|
7 314
|
8 006
|
9 263
|
9 510
|
10 433
|
|
| Goodwill |
17 325
|
18 311
|
17 622
|
18 877
|
19 589
|
20 895
|
21 300
|
22 428
|
24 286
|
24 639
|
|
| Note Receivable |
898
|
627
|
563
|
718
|
686
|
868
|
628
|
1 026
|
1 464
|
1 755
|
|
| Long-Term Investments |
1 143
|
854
|
1 027
|
1 241
|
1 157
|
769
|
2 410
|
2 386
|
2 564
|
422
|
|
| Other Long-Term Assets |
927
|
850
|
1 430
|
1 605
|
1 496
|
2 113
|
1 560
|
1 803
|
2 467
|
2 604
|
|
| Other Assets |
17 325
|
18 311
|
17 622
|
18 877
|
19 589
|
20 895
|
21 300
|
22 428
|
24 286
|
24 639
|
|
| Total Assets |
85 364
N/A
|
88 242
+3%
|
90 406
+2%
|
96 176
+6%
|
114 685
+19%
|
125 217
+9%
|
89 181
-29%
|
99 909
+12%
|
111 566
+12%
|
115 485
+4%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
7 294
|
6 121
|
7 495
|
11 362
|
10 201
|
10 903
|
5 205
|
5 677
|
8 213
|
8 563
|
|
| Accrued Liabilities |
728
|
1 142
|
1 460
|
1 812
|
2 162
|
2 403
|
2 382
|
2 482
|
2 287
|
2 659
|
|
| Short-Term Debt |
5 619
|
7 490
|
2 556
|
2 449
|
4 997
|
6 499
|
200
|
640
|
2 583
|
1 965
|
|
| Current Portion of Long-Term Debt |
5 732
|
7 311
|
2 847
|
1 762
|
978
|
2 827
|
501
|
4 516
|
949
|
1 026
|
|
| Other Current Liabilities |
1 678
|
2 581
|
2 402
|
2 662
|
2 558
|
3 559
|
2 201
|
2 601
|
3 692
|
4 677
|
|
| Total Current Liabilities |
21 051
|
24 644
|
16 759
|
20 047
|
20 897
|
26 190
|
10 488
|
15 916
|
17 724
|
18 890
|
|
| Long-Term Debt |
36 615
|
30 132
|
35 050
|
30 478
|
42 429
|
38 758
|
27 594
|
26 764
|
33 236
|
33 649
|
|
| Deferred Income Tax |
1 181
|
1 990
|
1 864
|
1 631
|
2 024
|
2 634
|
2 473
|
3 030
|
3 062
|
2 108
|
|
| Minority Interest |
330
|
381
|
393
|
515
|
1
|
0
|
0
|
22
|
75
|
128
|
|
| Other Liabilities |
1 590
|
2 194
|
2 765
|
3 670
|
1 245
|
1 595
|
1 210
|
1 035
|
3 626
|
6 627
|
|
| Total Liabilities |
60 108
N/A
|
58 579
-3%
|
56 046
-4%
|
55 311
-1%
|
66 596
+20%
|
69 178
+4%
|
41 766
-40%
|
46 723
+12%
|
57 574
+23%
|
61 146
+6%
|
|
| Equity | |||||||||||
| Common Stock |
154
|
155
|
156
|
156
|
159
|
159
|
159
|
159
|
159
|
159
|
|
| Retained Earnings |
19 320
|
22 980
|
28 204
|
33 957
|
40 874
|
48 453
|
43 668
|
53 026
|
53 834
|
45 650
|
|
| Additional Paid In Capital |
5 301
|
5 402
|
5 436
|
5 441
|
5 872
|
5 873
|
0
|
0
|
0
|
0
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Other Equity |
481
|
1 126
|
565
|
1 312
|
1 184
|
1 554
|
3 588
|
0
|
0
|
8 531
|
|
| Total Equity |
25 256
N/A
|
29 663
+17%
|
34 360
+16%
|
40 865
+19%
|
48 089
+18%
|
56 039
+17%
|
47 415
-15%
|
53 186
+12%
|
53 993
+2%
|
54 339
+1%
|
|
| Total Liabilities & Equity |
85 364
N/A
|
88 242
+3%
|
90 406
+2%
|
96 176
+6%
|
114 685
+19%
|
125 217
+9%
|
89 181
-29%
|
99 909
+12%
|
111 566
+12%
|
115 485
+4%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
159
|
159
|
159
|
159
|
159
|
159
|
159
|
159
|
159
|
158
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
